RxDoctor Payments Data

James Pate, APRN

Nurse Practitioner · Bolivia, NCNPI 1184062564

Payments from drug & device makers

$1,446in general payments, 2019–2025

Across 79 payments — averaging $18.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$618
  • Amgen$173
  • Pfizer$156
  • Irhythm Technologies, Inc.$128
  • Merck$83
  • AstraZeneca$83
  • plus $205 from 10 others

What the payments were for

  • Food & beverage$1,41198%
  • Education$362%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,446 in reported general payments places this provider in the 80th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina

Medicare billing

Part B allowed, 2024
$113,395
Medicare patients
905
Services billed
1,473

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban105$108,796
Repatha SureclickEvolocumab41$35,042
FarxigaDapagliflozin Propanediol30$30,192
EntrestoSacubitril/Valsartan34$27,594
XareltoRivaroxaban13$14,533
Metoprolol Succinate284$3,575
Ranolazine ErRanolazine51$2,840
Ezetimibe76$1,892
Atorvastatin Calcium195$1,630
Hydralazine Hcl125$1,536
Nitroglycerin144$1,533
Potassium Chloride126$1,504
Losartan Potassium166$1,299
Isosorbide Mononitrate ErIsosorbide Mononitrate122$1,275
Midodrine Hcl25$1,057

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$156$108,796105 claims
AstraZenecaFarxiga$83$30,19230 claims
NovartisEntresto$18$27,59434 claims
Johnson & JohnsonXarelto$18$14,53313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Bolivia

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →